We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Promising Cancer Immunotherapy Method Relies on Artificial Magnetic Antigen Presenting Cells

By LabMedica International staff writers
Posted on 26 Jul 2015
Print article
Image: Nanoscale artificial antigen presenting cells (nano-aAPCs) bound to receptors on the T-cell surface (Photo courtesy of Dr. Karlo Perica, Johns Hopkins University).
Image: Nanoscale artificial antigen presenting cells (nano-aAPCs) bound to receptors on the T-cell surface (Photo courtesy of Dr. Karlo Perica, Johns Hopkins University).
Image: Applying a magnetic field caused the nano-aAPCs—and their receptors—to cluster together, leading to T-cell stimulation (Photo courtesy of Dr. Karlo Perica, Johns Hopkins University).
Image: Applying a magnetic field caused the nano-aAPCs—and their receptors—to cluster together, leading to T-cell stimulation (Photo courtesy of Dr. Karlo Perica, Johns Hopkins University).
Cancer researchers have developed a method based on magnetic nanoparticles that enables the rapid extraction, enrichment, and expansion of a T-cell population that shows great promise as a tool for immunotherapy.

Adoptive immunotherapy can induce long term tumor regression, but widespread adoption of this approach has been limited by the cost and complexity of generating tumor-specific T-cells.

Investigators at Johns Hopkins University (Baltimore, MD, USA) developed an improved method for generating tumor-specific T-cells to use for adoptive immunotherapy. Their method employed paramagnetic, nanoscale artificial antigen presenting cells (aAPC) to rapidly expand tumor-specific T-cells from rare naïve precursors.

Thus far, aAPCs have been synthesized by coupling T-cell activating proteins such as CD3 or MHC-peptide to micron-sized beads. Nanoscale platforms have different trafficking and biophysical interaction properties and may allow development of new immunotherapeutic strategies. Thus, for the current study, the investigators manufactured aAPCs from biocompatible iron-dextran paramagnetic particles (50–100 nanometers in diameter).

Details of the methodology were present in a paper published in the July 14, 2015, online edition of the journal ACS Nano. The investigators mixed blood plasma from mice and, separately, humans with magnetic aAPCs that had been coated with tumor antigens. The plasma was passed through a magnetic column, and T-cells adhered to the aAPCs and were retained on the column. Other types of cells were washed through the column and discarded. The magnetic field of the column activated the T-cells, which were then washed off and cultured. After one week, their numbers had expanded by an estimated 5,000 to 10,000 times.

Senior author Dr. Jonathan Schneck, professor of pathology, medicine, and oncology at Johns Hopkins University, said, “The challenge has been to train these cells efficiently enough, and get them to divide fast enough, that we could use them as the basis of a therapy for cancer patients. We have taken a big step toward solving that problem.”

Related Links:

Johns Hopkins University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.